BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a Brca1 transgene-Reference-Cited by-同舟云学术

BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a Brca1 transgene

Published:1999-12 Issue:55 Volume:18 Page:7900-7907
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Snouwaert John N,Gowen Lori C,Latour Anne M,Mohn Amy R,Xiao Andrew,DiBiase Lauren,Koller Beverly H

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1203334.pdf

Reference49 articles.

1. Bennet LM, Haugen-Strano A, Cochran C, Brownlee HA, Fiedorek Jr FT and Wiseman R. . 1995 Genomics 29: 576–581.

2. Blackshear PE, Goldsworthy SM, Foley JF, McAllister KA, Bennet LM, Collins NK, Bunch DO, Brown P, Wiseman R and Davis BJ. . 1998 Oncogene 16: 61–68.

3. Callebaut I and Mornon J-P. . 1997 FEBS Lett. 400: 25–30.

4. Chambers JA and Solomon E. . 1996 Genomics 38: 305–313.

5. Chapman MS and Verma IM. . 1996 Nature 382: 678–679.

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Repetitive Sequence Stability in Embryonic Stem Cells;International Journal of Molecular Sciences;2024-08-13

2. Facing the conundrum: which first-line therapy should be used for patients with metastatic triple-negative breast cancer carrying germline BRCA mutation?;Exploration of Targeted Anti-tumor Therapy;2023-12-27

3. Arsenite Impairs BRCA1-Dependent DNA Double-Strand Break Repair, a Mechanism Potentially Contributing to Genomic Instability;International Journal of Molecular Sciences;2023-09-21

4. Contralateral breast cancer risk in patients with breast cancer and a germline-BRCA1/2 pathogenic variant undergoing radiation;JNCI: Journal of the National Cancer Institute;2023-06-27

5. BRCA1 and TP53 codeficiency causes a PARP inhibitor–sensitive erythroproliferative neoplasm;JCI Insight;2022-12-22